Skip to main content
. 2018 May 7;8:129. doi: 10.3389/fcimb.2018.00129

Table 4.

Demographics, clinical data and laboratory perameters at admission in HFRS patients with and without bacterial infection.

Variables Non-bacterial infection (n = 59) Bacterial infection (n = 87) P-value
Male, n (%) 46 (42.2) 63 (57.8) 0.449
Age, years 41.93 ± 14.53 47.05 ± 16.82 0.059
Max temperature, °C 38.86 ± 0.75 39.07 ± 0.74 0.097
Admitted days after fever 5.80 ± 2.66 6.18 ± 4.04 0.518
SBP, mmHg 121.80 ± 20.24 119.78 ± 17.10 0.518
DBP, mmHg 78.03 ± 13.48 78.00 ± 14.87 0.989
Smoking, n (%) 32(54.2) 39 (44.8) 0.264
Alcohol consumption, n (%) 30 (50.8) 36 (41.4) 0.259
COMORBIDITY
Hypertension, n (%) 10 (16.9) 13 (14.9) 0.744
Diabetes mellitusm, n (%) 2 (3.4) 5 (5.7) 0.513
Coronary heart disease, n (%) 1 (1.7) 4 (4.6) 0.344
HFRS-RELATED COMPLICATION
Hemorrhage, n (%) 33 (55.9) 50 (57.5) 0.854
Hepatic injury, n (%) 30 (50.8) 48 (55.2) 0.607
Sepsis, n (%) 1 (1.7) 5 (5.7) 0.226
MODS, n (%) 2 (3.4) 6 (6.9) 0.361
Arrhythmia, n (%) 2 (3.4) 7 (8.0) 0.251
Blood transfusion, n (%) 18 (30.5) 37 (42.5) 0.141
CRRT, n (%) 13 (22) 26 (29.9) 0.293
Hospital stay, days 12.32 ± 7.26 13.30 ± 7.06 0.419
Number of deaths, n (%) 2 (3.4) 11 (12.6) 0.054
PARAMETERS
WBC, × 109 cells/L 11.79 ± 8.32 12.06 ± 7.08 0.831
PLT, × 109 cells/L 82.19 ± 74.46 84.28 ± 79.17 0.873
Neutrophils percentage, (%) 64.05 ± 13.01 69.56 ± 16.07 0.031
Lymphocytes percentage, (%) 25.62 ± 11.37 20.20 ± 12.24 0.008
PCT,(ng/ml) 0.94(0.05-25.00) 2.00 (0.03–62.91) 0.016
Lg PCT 0.02 ± 0.68 0.27 ± 0.69 0.037

SBP, systolic blood pressure; DBP, diastolic blood pressure; MODS, multiple organ dysfunction syndrome; CRRT, continuous renal replacement therapy; WBC, white blood cell counts; PLT, platelet; PCT, procalcitonin; Lg PCT, procalcitonin after log10 transformationn.